Prospective Follow-up of a Multicentric Cohort of Children With Prenatal Discovery of Mild Isolated Cerebral Ventriculomegaly. Evaluation at 2 and 5 Years.
NCT ID: NCT00421772
Last Updated: 2007-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
245 participants
OBSERVATIONAL
2007-01-31
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The prognostic of ventriculomegaly remains dubious : the studies have small populations, are for the majority retrospectives with a short and often vague follow-up. The announced rate of after-effects varies between 0 and 48 %.
The objective of this study is to evaluate the neuropsychological development until the 5 years age of the children for whom a prenatally diagnosis of mild isolated ventriculomegaly was carried (absence of another cerebral or extra-cerebral anomaly in imagery and a negative aetiology). This prospective cohort will be compared with children for whom no neurological anomaly was prenatally detected.
The children diagnosed for an mild isolated cerebral ventriculomegaly will be identified by the investigators among medical files of the Centers of Prenatal Diagnosis (CPDPN) of the UH of Angers and the UH of Nantes. The patient inclusion will be done at the 2 years age after parental agreement, with a follow-up at 5 years. The control children will be included under the same conditions after having ensured of the normality of the echographies of 22 and 30 gestational weeks. The follow-up of these 2 cohorts will be based on the 2 years obligatory paediatric examination, and on the network "Naitre ensemble" set up in the Pays de la Loire Loire. In addition to the clinical routine examinations, standardized neuropsychological examinations will be done (Brunet Lezine Revised score at 2 years, NEPSY at 5 years and ASQ at 2 and 5 years).
This study will allow to compare the neuropsychological development at school age of the children diagnosed for a foetal mild, apparently isolated, cerebral ventriculomegaly from children not presenting any foetal anomaly, to evaluate the incidence of the mild isolated ventriculomegaly, to identify the predictive factors of the neuropsychological anomalies in the children diagnosed for ventriculomegaly and to compare (in the children diagnosed for ventriculomegaly), the neuropsychological development at the school age of the children having a ventricular atrium between 10 and 12 mm with those having a ventricular atrium between 12,1 and 15 mm.
This study will allow to define the neuropsychological morbidity of the foetal mild isolated cerebral ventriculomegaly and will allow to define the best clinical and educational follow up of these children and their family.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years
NCT04812210
Quality of Life Among Children With Congenital Heart Disease
NCT01202916
Epidemiology of Congenital Heart Disease in France
NCT04740177
Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle
NCT05118152
Evolution of Cardiopulmonary Fitness in Children With Congenital Heart Disease
NCT04815577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of foetal mild isolated cerebral ventriculomegaly at 32 gestational weeks by the Centers of Prenatal Diagnosis (CPDPN) of the UH of Angers and the UH of Nantes
* Age : 22 to 26 months
* Written informed consent
* Negative diagnostic of foetal cerebral ventriculomegaly at the prenatal echography made at 22 gestational weeks
* Age : 22 to 26 months
* Preterm birth (\< 37 weeks of gestation)
* APGAR ≤ 3 at 5 minutes after birth
* Serious prenatal pathology with neurologic aspect requing intensive care
* postnatal hydrocephalus
* Diagnostic of a eurological pathology at birth
* Diagnostic d'une pathologie neurologique associée à la naissance
* Preterm birth (\< 37 weeks of gestation)
* APGAR ≤ 3 at 5 minutes after birth
* Serious prenatal pathology with neurologic aspect requing intensive care
* postnatal hydrocephalus
* Diagnostic of a neurological pathology at birth
* Cerebral or extracerebral anomaly at the prenatal echographies
* Chromosomal anomaly discovered after birth
22 Months
26 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
University Hospital, Angers
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claude BOUDERLIQUE, MD
Role: PRINCIPAL_INVESTIGATOR
UH of Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UH of Angers
Angers, , France
UH of Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Norbert WINER, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DGS : 2006/0432
Identifier Type: -
Identifier Source: secondary_id
CCPPRB : 2006/08
Identifier Type: -
Identifier Source: secondary_id
PHRC-05-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.